These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 1083749)

  • 1. T-cell qualities of lymphocytes and/or leukemic cells from peripheral blood in acute myeloid and lymphatic leukemia before treatment and at relapse.
    de Vaan GA; Bakkeren JA; Schretlen ED
    Biomedicine; 1975 Nov; 22(6):524-31. PubMed ID: 1083749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.
    Wiley JS; Taupin J; Jamieson GP; Snook M; Sawyer WH; Finch LR
    J Clin Invest; 1985 Feb; 75(2):632-42. PubMed ID: 3871794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivity of B leukemic lymphocytes of patients with chronic lymphocytic leukemia to PWM and PHA.
    Isaković K; Lenert G
    Blood Cells; 1987; 12(2):355-64. PubMed ID: 3497681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivity of antihuman thymocyte serum with acute leukemic blasts.
    Mills B; Sen L; Borella L
    J Immunol; 1975 Oct; 115(4):1038-44. PubMed ID: 1100719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface markers and prognostic factors in acute lymphoblastic leukemia.
    Tsukimoto I; Wong KY; Lampkin BC
    N Engl J Med; 1976 Jan; 294(5):245-8. PubMed ID: 53789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E receptors on blasts from untreated acute lymphocytic leukemia (ALL): comparison of temperature dependence of E rosettes formed by normal and leukemic lymphoid cells.
    Borella L; Sen L
    J Immunol; 1975 Jan; 114(1 Pt 1):187-90. PubMed ID: 1089710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
    Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A
    Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
    Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte immunological patterns in leukaemia: a review.
    Atsaldi G; Astaldi GC; Topuz U; Guarina L
    Haematologia (Budap); 1975; 9(1-2):21-33. PubMed ID: 780227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of human T lymphocytes to bind sheep erythrocytes and mitogenic responses of their subpopulations.
    Sasaki M; Sekizawa T; Takahashi H; Abo T; Kumagai K
    J Immunol; 1975 Dec; 115(6):1509-14. PubMed ID: 1081102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation.
    Parkman R; Cohen G; Carter SL; Weinberg KI; Masinsin B; Guinan E; Kurtzberg J; Wagner JE; Kernan NA
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):919-27. PubMed ID: 16920557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel cell surface antigen (T305) found in increased frequency on acute leukemia cells and in autoimmune disease states.
    Fox RI; Hueniken M; Fong S; Behar S; Royston I; Singhal SK; Thompson L
    J Immunol; 1983 Aug; 131(2):762-7. PubMed ID: 6602845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human thymus cells: blastogenic response to mitogens, antigens and allogeneic cells.
    Han T; Minowada J; Subramanian S; Sinks LF
    Immunology; 1976 Oct; 31(4):519-25. PubMed ID: 135725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
    Pattengale PK; Sundstrom C; Yu AL; Levine A
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
    Greaves MF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
    Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
    Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunological classification of acute lymphoblastic leukemias (author's transl)].
    Tubiana N; Derre M; Carcassonne Y
    Sem Hop; 1980 Dec 18-25; 56(47-68):1993-7. PubMed ID: 6256912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serological diagnosis of the antigenic markers of acute lymphatic leukaemias and non-Hodgkin lymphomas in childhood (author's transl)].
    Thränhardt H; Zintl F; Plenert W
    Arch Geschwulstforsch; 1978; 48(4):289-300. PubMed ID: 308796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PHA stimulation of separated human lymphocyte populations.
    Potter MR; Moore M
    Clin Exp Immunol; 1975 Sep; 21(3):456-67. PubMed ID: 1106926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.